QIAGEN OmicSoft
Drug Target and Biomarker Investigation using OmicSoft OncoLand
130 views
Key focus will be on Biomarker discovery with QIAGEN OmicSoft OncoLand leveraging public oncology data from GEO, TCGA and other collections to:
• Discover and validate biomarker expression in diseases, disease subtypes, treatments, cell types, etc.
• Identify a list of biomarkers specifically expressed in disease, treatment group, cell type or other condition of interest
• Overlay expression of a gene on cell clusters of interest from public single-cell data
This training is designed for biologists, bioinformaticians, and data scientists.
Related videos
QIAGEN IPA
Systems analysis of cancer cell lines for drug target discovery
Cancer cell line models have been a cornerstone of cancer research for...
QIAGEN OmicSoft
Human-certified ‘omics data to power drug discovery
Integrating external and internal ‘omics data is a key element of hypothesis...
QIAGEN OmicSoft
QIAGEN OmicSoft trainings- 3 part series - Oct 22 (part 3)
In three separate 60-minute trainings, attendees will learn how to use basic...
QIAGEN OmicSoft
QIAGEN OmicSoft trainings- 3 part series - Oct 21 (part 2)
In three separate 60-minute trainings, attendees will learn how to use basic...